159 related articles for article (PubMed ID: 3386411)
1. Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.
Halbrügge T; Gerhardt T; Ludwig J; Heidbreder E; Graefe KH
Life Sci; 1988; 43(1):19-26. PubMed ID: 3386411
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity.
Ludwig J; Gerhardt T; Halbrügge T; Walter J; Graefe KH
Eur J Clin Pharmacol; 1988; 35(3):261-7. PubMed ID: 3181279
[TBL] [Abstract][Full Text] [Related]
3. Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives.
Ludwig J; Gerhardt T; Halbrügge T; Walter J; Heidbreder E; Graefe KH
J Hum Hypertens; 1990 Dec; 4(6):693-701. PubMed ID: 2096212
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects on presynaptic noradrenaline metabolism.
Ludwig J; Halbrügge T; Graefe KH
J Neural Transm Suppl; 1991; 34():69-75. PubMed ID: 1817166
[TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
Itoh Y; Oishi R; Nishibori M; Saeki K
J Pharmacol Exp Ther; 1990 Dec; 255(3):1090-7. PubMed ID: 2262894
[TBL] [Abstract][Full Text] [Related]
6. Estimation of noradrenaline concentrations in the axoplasm of noradrenergic neurones in man.
Ludwig J; Halbrügge T; Gerlich M; Graefe KH
Clin Auton Res; 1992 Jun; 2(3):159-64. PubMed ID: 1498562
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous liquid chromatographic determination of norepinephrine, 3,4-dihydroxyphenylethyleneglycol, 3,4-dihydroxyphenylalanine and 3,4-dihydroxyphenylacetic acid in human plasma.
Premel-Cabic A; Allain P
J Chromatogr; 1988 Dec; 434(1):187-90. PubMed ID: 3149644
[No Abstract] [Full Text] [Related]
8. Plasma levels of free and total catecholamines and two deaminated metabolites in man--rapid deconjugation by heat in acid.
Vlachakis ND; Kogosov E; Yoneda S; Alexander N; Maronde RF
Clin Chim Acta; 1984 Feb; 137(2):199-209. PubMed ID: 6705233
[TBL] [Abstract][Full Text] [Related]
9. Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromocytoma.
Mizukoshi M; Hano T; Kuchii M; Nishio I; Masuyama Y
Jpn Circ J; 1985 Sep; 49(9):1035-42. PubMed ID: 4068201
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of human plasma catecholamines by high-performance liquid chromatography with a reversed-phase triacontylsilyl silica column.
Machida M; Sakaguchi A; Kamada S; Fujimoto T; Takechi S; Kakinoki S; Nomura A
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):249-54. PubMed ID: 16301006
[TBL] [Abstract][Full Text] [Related]
11. Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit.
Halbrügge T; Wölfel R; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):726-32. PubMed ID: 2634246
[TBL] [Abstract][Full Text] [Related]
12. Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.
Azorin JM; Karege F; Valli M; Pringuey D; Joanny P; Tissot R
Neuropsychobiology; 1988; 20(2):67-73. PubMed ID: 3075724
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Eisenhofer G; Goldstein DS; Stull R; Keiser HR; Sunderland T; Murphy DL; Kopin IJ
Clin Chem; 1986 Nov; 32(11):2030-3. PubMed ID: 3096593
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.
Ludwig J; Halbrügge T; Vey G; Walter J; Graefe KH
Eur J Clin Pharmacol; 1989; 37(5):493-500. PubMed ID: 2598988
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebivolol stereoisomers on the action of adrenaline on blood pressure, heart rate and blood levels of noradrenaline and DOPEG.
Borges N; Martel F; Branco D; Osswald W
J Auton Pharmacol; 1992 Dec; 12(6):429-35. PubMed ID: 1361931
[TBL] [Abstract][Full Text] [Related]
16. Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.
Halbrügge T; Friedgen B; Ludwig J; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):162-70. PubMed ID: 8474537
[TBL] [Abstract][Full Text] [Related]
17. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B
Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900
[TBL] [Abstract][Full Text] [Related]
18. [Physiologic variability of plasma catecholamines].
Pluto R; Bürger P; Weicker H
Klin Wochenschr; 1986 Jul; 64(14):625-32. PubMed ID: 3762012
[TBL] [Abstract][Full Text] [Related]
19. Determination of 3,4-dihydroxyphenylglycol (DHPG) by HPLC with coulometric detection, and correlation with 3-methoxy-4-hydroxyphenylglycol (MHPG) in human plasma.
Karege F; Gaillard JM; Tissot R; Azorin JM; Valli M
Biomed Chromatogr; 1987 Feb; 2(1):30-3. PubMed ID: 3508091
[TBL] [Abstract][Full Text] [Related]
20. The importance of plasma 3,4-dihydroxyphenylglycol (DOPEG) in analyses of the sympathetic nervous system in vivo.
Graefe KH; Halbrügge T; Gerlich M; Ludwig J
J Neural Transm Suppl; 1990; 32():421-9. PubMed ID: 2089106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
